RESEARCH
"Sarcoma 0-40"
"Sarcoma 0-40"
Understanding and treating sarcomas and mesenchymal tumors remain major challenges in cancer research and represent an unmet clinical need. To make a significant impact on sarcomas affecting children and young adults, the RTICC (Technion) has joined forces with the Case Comprehensive Cancer Center (CCCC) at Case Western Reserve University in Cleveland and the Department of Pediatrics at the Indiana University School of Medicine. Together, we have established an international, multi-center consortium termed “Sarcoma 0–40,” which focuses primarily on Ewing sarcoma and osteosarcoma in pediatric and young adult populations.
"Sarcoma 0-40" Call for Proposals
To make a significant impact on sarcomas in children and young adults, the RTICC (Technion) joined forces with the Case Comprehensive Cancer Center (CCCC) at Case Western Reserve University in Cleveland and the Department of Pediatrics at Indiana University School of Medicine to establish an international multicenter initiative called "Sarcoma 0-40."
We invite Faculty members of the RTICC, CCCC, and Department of Pediatrics at Indiana University School of Medicine to apply for the collaborative joint grants.
The funding will foster synergy between partner institutions (at least two, with the RTICC being one of them at this stage) by combining their complementary expertise, while offering co-mentoring to students, post-doctoral or clinical fellows, as well as hands-on experience in both laboratories.
Submission Deadline: April 30th, 2026
"Sarcoma 0-40" Researchers
Indiana University, School of Medicine, Department of Pediatrics
Prof. Wade Clapp, MD
Use of Proteomics and Preclinical Models Identify Molecular Vulnerabilities of NF1 PNSTs
Prof. Karen E. Pollok
Precision Genomics& Preclinical Modeling
Asst. Prof. Pankita H. Pandya
Precision Genomics& Preclinical Modeling
Prof. Ed Greenfield
Osteosarcoma
Asst. Prof. Chris Collier, MD
Understanding the Intersection of Orthopaedics and Cancer
Prof. Brian D Weiss, MD
Division Chief for Pediatric Hematology/Oncology/Stem Cell Transplant
Asst. Prof. Kyle Jackson
The Biology of Underlying Pediatric Bone Sarcomas
Dr. Marissa Just
Soft Tissue Sarcomas, Rhabdomyosarcoma
Case Comprehensive Cancer Center, Case Western Reserve University
Prof. Gary Schwartz, MD
Citruvivint and Ewing Sarcoma
Asst. Prof. Berkley Gryder
Epigenetics & 3D Genomics, Drug Discovery & Development
Asst. Prof. Alex Y. Huang, MD, PhD
Cellular & Molecular Immunology & Tumor Immunity
Assoc. Prof. Reshmi Parameswaran
OSM CAR-T Therapy for Sarcomas
Asst. Prof. Rebecca Obeng, MD, PhD, MPH
Therapeutic Remodeling the Tumor Immune Microenvironment
Prof. Seth Corey
Animal Models, Ewing Sarcoma
RTICC Rappaport Cancer Research Center, Technion-Israel Institute of Technology
Prof. Amir Orian, MD, PhD
RNF4-LOX axis in Sarcoma
Prof. Peleg Hasson
Tissue Development & Regeneration
Dr. Oz Mordechai, MD
Pediatric Sarcoma, genetics, precision medicine, and immuno-oncology
Distinguished Prof. Aaron Ciechanover
Ubiquitin-related Therapy in Sarcoma
Dr. Dana Ashkenazi Lustig, MD
From Rare Pediatric Cancers to Precision Nanotherapy
Clin. Assoc. Prof. Alona Zer, MD
Kaposi Sarcoma
Assoc. Prof. Yosi Shamay
Cancer Nanomedicine and Nanoinformatics
Prof. Myriam Ben Arush, MD
Rhabdomyosarcoma and new drugs in pediatric sarcomas
Assoc. Prof. Shenhav Shemer
Biomarkers and pathways of muscle atrophy
Dr. David Nikomarov, MD
Director of Orthopedic Oncology Surgery at Rambam Medical Center.
Dr. Rostislav Novak, MD
Role of LOX proteins in TME remodeling and metastatic progression
Prof. Yuval Shaked
Host response to therapy
Assoc. Prof. Moti Freiman
AI-enabled quantitative MRI for Sarcoma management
Prof. Hadar Zigdon-Giladi, MD
Structural and mechanical alterations in the bone microenvironment
Or-Yam Revach, PhD
Tumor Immunology and Immunotherapy
Prof. Alejandro Sosnik
Novel hybrid nanomaterials for targeted sonodynamic therapy
Prof. Israel Vlodavsky
role of Hpa2 in sarcoma
